Status:
SUSPENDED
The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, Biomechanics, and Pain Intensity
Lead Sponsor:
Mayo Clinic
Conditions:
Gluteus Medius Muscle Strength
Lateral Hip Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
We hypothesize that the addition of a unilateral neutral shoe insert combined with standard physical therapy (PT+SI) will have greater improvements in pain and function at 12 weeks and 6 months compar...
Eligibility Criteria
Inclusion
- Subjects with a history of unilateral hip pain lasting more than three months.
- Subjects with a VAS pain score of at least 3/10 localized to the lateral hip.
- Subjects with pain with palpation to lateral hip.
- Subjects with pain with either resisted hip abduction in relative adduction testing position and/or single leg stance test
Exclusion
- Subjects wearing custom foot orthoses at the time of recruitment.
- Subjects who endorse current low back pain ≥ 3 on the NRS or lumbar radiculopathy
- Subjects with a medical history of spinal or lower limb surgery in the past 6 months.
- Subjects with a medical history of total joint replacement of hip, knee, or ankle on the symptomatic side
- Subjects who have had a corticosteroid injection at the hip within the last 12 months;
- Subjects demonstrating clinical signs and symptoms of intra-articular hip joint pathology with ≥ 3/10 groin pain including imaging confirmed significant labral tearing requiring surgery or osteoarthritis \> 2 (mild) on Kellgren-Lawrence score on radiographs.
- Subjects previously diagnosed with systemic inflammatory conditions; active cancer/malignant tumors; or neurological conditions that would affect gait
- Subjects who have had physical therapy within the past 3 months for hip pain
- If subjects are unable to commit to 12 weeks of therapy with one supervised session weekly
- Subjects who have the intention to perform treatments outside of this study including, but not limited to, dry needling or acupuncture, extracorporeal shockwave, therapeutic ultrasound, a TENEX procedure, medication injection therapies, platelet-rich plasma injections, stem cell injections, and surgery.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06891001
Start Date
December 1 2025
End Date
January 1 2028
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Glendale, Arizona, United States, 85031